Annapoorna Kini is a Cardiology physician affiliated with Mount Sinai Health System. OpenAlex indexes 1,147 publications with 18,112 citations (h-index 60); ClinicalTrials.gov lists 7 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Interventional Cardiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5 E 98th St
3rd Floor
New York, NY 100296501
Telephone
212-241-5586Registry record last updated 20 Jul 2012.
Clinical trials
- Rosuvastatin and Evolocumab for Coronary Artery Disease
Sponsor: Icahn School of Medicine at Mount Sinai
- The Effect of Structured Lifestyle Modification and Yoga Practice on Metabolic Processes Associated With Cardiovascular Disease
Sponsor: Icahn School of Medicine at Mount Sinai
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20253 payments$36,000openpaymentsdata.cms.gov ↗
- Shockwave Medical, IncProgram year20252 payments
- Abbott LaboratoriesProgram year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
60.3%Beta blocker15%Metoprolol Succinate70%Metoprolol Tartrate30%Part D<11 patientsStatin14.8%Atorvastatin Calcium71%Rosuvastatin Calcium29%Part D≥26 patients+ 6 more classes in this area
Blood & clotting
27.7%P2Y12 inhibitor27.7%Clopidogrel84%Prasugrel Hcl17%Part D≥52 patientsMetabolism & gastrointestinal
12%Proton pump inhibitor7.2%Pantoprazole Sodium100%Part D≥16 patientsCorticosteroid4.8%Prednisone100%Part D≥22 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Stamatios Lerakis, MD
Mount Sinai Health System
Stanley Yancovitz, MD
Mount Sinai Health System
Vivek Yerrapu Reddy
Mount Sinai Health System
Robert Desnick, PhD, MD
Mount Sinai Health System
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”